TrialViruses2012

Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults.

Jessica A Chichester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.